Global Nanopharmaceuticals Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Nanopharmaceuticals Market
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their "bulk" counterparts primarily because of size.

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.

Due to the COVID-19 pandemic, the global Nanopharmaceuticals market size is estimated to be worth US$ 35330 million in 2022 and is forecast to a readjusted size of US$ 73550 million by 2028 with a CAGR of 13.0% during the review period. Fully considering the economic change by this health crisis, Liposomes accounting for % of the Nanopharmaceuticals global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Cancer and Tumor segment is altered to an % CAGR throughout this forecast period.

USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share.

The key players are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy etc. Top 3 companies occupied about 34% market share.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Liposomes

Polymeric Micelles

Solid Lipid Nanoparticles

Microemulsion and Nnanoemulsion

Nanosuspension

Segment by Application

Cancer and Tumor

Autoimmune Disorders

Inflammation

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Nanopharmaceuticals market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Merck

Pfizer

Novartis

Abbott

GlaxoSmithKline

Roche

Sanofi

Eli Lilly

Astrazeneca

Johnson & Johnson

Celgene

Novavax

Stryker

Gilead Sciences

OSI Pharmaceuticals

Kadmon Pharmaceuticals

Samyang Biopharm

Mitsubishi Pharma

Kaken Pharmaceutical

Selecta Biosciences

Par Pharmaceutical

Cerulean Pharma

Navidea Biopharmaceuticals

Lummy

TABLE OF CONTENT

1 Study Coverage
1.1 Nanopharmaceuticals Product Introduction

1.2 Market by Type

1.2.1 Global Nanopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Liposomes

1.2.3 Polymeric Micelles

1.2.4 Solid Lipid Nanoparticles

1.2.5 Microemulsion and Nnanoemulsion

1.2.6 Nanosuspension

1.3 Market by Application

1.3.1 Global Nanopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Cancer and Tumor

1.3.3 Autoimmune Disorders

1.3.4 Inflammation

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Nanopharmaceuticals Sales Estimates and Forecasts 2017-2028

2.2 Global Nanopharmaceuticals Revenue Estimates and Forecasts 2017-2028

2.3 Global Nanopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Nanopharmaceuticals Sales by Region

2.4.1 Global Nanopharmaceuticals Sales by Region (2017-2022)

2.4.2 Global Sales Nanopharmaceuticals by Region (2023-2028)

2.5 Global Nanopharmaceuticals Revenue by Region

2.5.1 Global Nanopharmaceuticals Revenue by Region (2017-2022)

2.5.2 Global Nanopharmaceuticals Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Nanopharmaceuticals Sales by Manufacturers

3.1.1 Global Top Nanopharmaceuticals Manufacturers by Sales (2017-2022)

3.1.2 Global Nanopharmaceuticals Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nanopharmaceuticals in 2021

3.2 Global Nanopharmaceuticals Revenue by Manufacturers

3.2.1 Global Nanopharmaceuticals Revenue by Manufacturers (2017-2022)

3.2.2 Global Nanopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Nanopharmaceuticals Revenue in 2021

3.3 Global Nanopharmaceuticals Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Nanopharmaceuticals Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Nanopharmaceuticals Sales by Type

4.1.1 Global Nanopharmaceuticals Historical Sales by Type (2017-2022)

4.1.2 Global Nanopharmaceuticals Forecasted Sales by Type (2023-2028)

4.1.3 Global Nanopharmaceuticals Sales Market Share by Type (2017-2028)

4.2 Global Nanopharmaceuticals Revenue by Type

4.2.1 Global Nanopharmaceuticals Historical Revenue by Type (2017-2022)

4.2.2 Global Nanopharmaceuticals Forecasted Revenue by Type (2023-2028)

4.2.3 Global Nanopharmaceuticals Revenue Market Share by Type (2017-2028)

4.3 Global Nanopharmaceuticals Price by Type

4.3.1 Global Nanopharmaceuticals Price by Type (2017-2022)

4.3.2 Global Nanopharmaceuticals Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Nanopharmaceuticals Sales by Application

5.1.1 Global Nanopharmaceuticals Historical Sales by Application (2017-2022)

5.1.2 Global Nanopharmaceuticals Forecasted Sales by Application (2023-2028)

5.1.3 Global Nanopharmaceuticals Sales Market Share by Application (2017-2028)

5.2 Global Nanopharmaceuticals Revenue by Application

5.2.1 Global Nanopharmaceuticals Historical Revenue by Application (2017-2022)

5.2.2 Global Nanopharmaceuticals Forecasted Revenue by Application (2023-2028)

5.2.3 Global Nanopharmaceuticals Revenue Market Share by Application (2017-2028)

5.3 Global Nanopharmaceuticals Price by Application

5.3.1 Global Nanopharmaceuticals Price by Application (2017-2022)

5.3.2 Global Nanopharmaceuticals Price Forecast by Application (2023-2028)

6 North America

6.1 North America Nanopharmaceuticals Market Size by Type

6.1.1 North America Nanopharmaceuticals Sales by Type (2017-2028)

6.1.2 North America Nanopharmaceuticals Revenue by Type (2017-2028)

6.2 North America Nanopharmaceuticals Market Size by Application

6.2.1 North America Nanopharmaceuticals Sales by Application (2017-2028)

6.2.2 North America Nanopharmaceuticals Revenue by Application (2017-2028)

6.3 North America Nanopharmaceuticals Market Size by Country

6.3.1 North America Nanopharmaceuticals Sales by Country (2017-2028)

6.3.2 North America Nanopharmaceuticals Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Nanopharmaceuticals Market Size by Type

7.1.1 Europe Nanopharmaceuticals Sales by Type (2017-2028)

7.1.2 Europe Nanopharmaceuticals Revenue by Type (2017-2028)

7.2 Europe Nanopharmaceuticals Market Size by Application

7.2.1 Europe Nanopharmaceuticals Sales by Application (2017-2028)

7.2.2 Europe Nanopharmaceuticals Revenue by Application (2017-2028)

7.3 Europe Nanopharmaceuticals Market Size by Country

7.3.1 Europe Nanopharmaceuticals Sales by Country (2017-2028)

7.3.2 Europe Nanopharmaceuticals Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Nanopharmaceuticals Market Size by Type

8.1.1 Asia Pacific Nanopharmaceuticals Sales by Type (2017-2028)

8.1.2 Asia Pacific Nanopharmaceuticals Revenue by Type (2017-2028)

8.2 Asia Pacific Nanopharmaceuticals Market Size by Application

8.2.1 Asia Pacific Nanopharmaceuticals Sales by Application (2017-2028)

8.2.2 Asia Pacific Nanopharmaceuticals Revenue by Application (2017-2028)

8.3 Asia Pacific Nanopharmaceuticals Market Size by Region

8.3.1 Asia Pacific Nanopharmaceuticals Sales by Region (2017-2028)

8.3.2 Asia Pacific Nanopharmaceuticals Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Nanopharmaceuticals Market Size by Type

9.1.1 Latin America Nanopharmaceuticals Sales by Type (2017-2028)

9.1.2 Latin America Nanopharmaceuticals Revenue by Type (2017-2028)

9.2 Latin America Nanopharmaceuticals Market Size by Application

9.2.1 Latin America Nanopharmaceuticals Sales by Application (2017-2028)

9.2.2 Latin America Nanopharmaceuticals Revenue by Application (2017-2028)

9.3 Latin America Nanopharmaceuticals Market Size by Country

9.3.1 Latin America Nanopharmaceuticals Sales by Country (2017-2028)

9.3.2 Latin America Nanopharmaceuticals Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Nanopharmaceuticals Market Size by Type

10.1.1 Middle East and Africa Nanopharmaceuticals Sales by Type (2017-2028)

10.1.2 Middle East and Africa Nanopharmaceuticals Revenue by Type (2017-2028)

10.2 Middle East and Africa Nanopharmaceuticals Market Size by Application

10.2.1 Middle East and Africa Nanopharmaceuticals Sales by Application (2017-2028)

10.2.2 Middle East and Africa Nanopharmaceuticals Revenue by Application (2017-2028)

10.3 Middle East and Africa Nanopharmaceuticals Market Size by Country

10.3.1 Middle East and Africa Nanopharmaceuticals Sales by Country (2017-2028)

10.3.2 Middle East and Africa Nanopharmaceuticals Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Merck

11.1.1 Merck Corporation Information

11.1.2 Merck Overview

11.1.3 Merck Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Merck Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Merck Recent Developments

11.2 Pfizer

11.2.1 Pfizer Corporation Information

11.2.2 Pfizer Overview

11.2.3 Pfizer Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Pfizer Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Pfizer Recent Developments

11.3 Novartis

11.3.1 Novartis Corporation Information

11.3.2 Novartis Overview

11.3.3 Novartis Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Novartis Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Novartis Recent Developments

11.4 Abbott

11.4.1 Abbott Corporation Information

11.4.2 Abbott Overview

11.4.3 Abbott Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Abbott Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Abbott Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Corporation Information

11.5.2 GlaxoSmithKline Overview

11.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 GlaxoSmithKline Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 GlaxoSmithKline Recent Developments

11.6 Roche

11.6.1 Roche Corporation Information

11.6.2 Roche Overview

11.6.3 Roche Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Roche Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Roche Recent Developments

11.7 Sanofi

11.7.1 Sanofi Corporation Information

11.7.2 Sanofi Overview

11.7.3 Sanofi Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Sanofi Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Sanofi Recent Developments

11.8 Eli Lilly

11.8.1 Eli Lilly Corporation Information

11.8.2 Eli Lilly Overview

11.8.3 Eli Lilly Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Eli Lilly Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Eli Lilly Recent Developments

11.9 Astrazeneca

11.9.1 Astrazeneca Corporation Information

11.9.2 Astrazeneca Overview

11.9.3 Astrazeneca Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Astrazeneca Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Astrazeneca Recent Developments

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Corporation Information

11.10.2 Johnson & Johnson Overview

11.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Johnson & Johnson Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Johnson & Johnson Recent Developments

11.11 Celgene

11.11.1 Celgene Corporation Information

11.11.2 Celgene Overview

11.11.3 Celgene Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Celgene Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Celgene Recent Developments

11.12 Novavax

11.12.1 Novavax Corporation Information

11.12.2 Novavax Overview

11.12.3 Novavax Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Novavax Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Novavax Recent Developments

11.13 Stryker

11.13.1 Stryker Corporation Information

11.13.2 Stryker Overview

11.13.3 Stryker Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 Stryker Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Stryker Recent Developments

11.14 Gilead Sciences

11.14.1 Gilead Sciences Corporation Information

11.14.2 Gilead Sciences Overview

11.14.3 Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.14.4 Gilead Sciences Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Gilead Sciences Recent Developments

11.15 OSI Pharmaceuticals

11.15.1 OSI Pharmaceuticals Corporation Information

11.15.2 OSI Pharmaceuticals Overview

11.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.15.4 OSI Pharmaceuticals Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 OSI Pharmaceuticals Recent Developments

11.16 Kadmon Pharmaceuticals

11.16.1 Kadmon Pharmaceuticals Corporation Information

11.16.2 Kadmon Pharmaceuticals Overview

11.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Kadmon Pharmaceuticals Recent Developments

11.17 Samyang Biopharm

11.17.1 Samyang Biopharm Corporation Information

11.17.2 Samyang Biopharm Overview

11.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.17.4 Samyang Biopharm Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Samyang Biopharm Recent Developments

11.18 Mitsubishi Pharma

11.18.1 Mitsubishi Pharma Corporation Information

11.18.2 Mitsubishi Pharma Overview

11.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.18.4 Mitsubishi Pharma Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 Mitsubishi Pharma Recent Developments

11.19 Kaken Pharmaceutical

11.19.1 Kaken Pharmaceutical Corporation Information

11.19.2 Kaken Pharmaceutical Overview

11.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.19.4 Kaken Pharmaceutical Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.19.5 Kaken Pharmaceutical Recent Developments

11.20 Selecta Biosciences

11.20.1 Selecta Biosciences Corporation Information

11.20.2 Selecta Biosciences Overview

11.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.20.4 Selecta Biosciences Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.20.5 Selecta Biosciences Recent Developments

11.21 Par Pharmaceutical

11.21.1 Par Pharmaceutical Corporation Information

11.21.2 Par Pharmaceutical Overview

11.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.21.4 Par Pharmaceutical Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.21.5 Par Pharmaceutical Recent Developments

11.22 Cerulean Pharma

11.22.1 Cerulean Pharma Corporation Information

11.22.2 Cerulean Pharma Overview

11.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.22.4 Cerulean Pharma Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.22.5 Cerulean Pharma Recent Developments

11.23 Navidea Biopharmaceuticals

11.23.1 Navidea Biopharmaceuticals Corporation Information

11.23.2 Navidea Biopharmaceuticals Overview

11.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.23.5 Navidea Biopharmaceuticals Recent Developments

11.24 Lummy

11.24.1 Lummy Corporation Information

11.24.2 Lummy Overview

11.24.3 Lummy Nanopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.24.4 Lummy Nanopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.24.5 Lummy Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Nanopharmaceuticals Industry Chain Analysis

12.2 Nanopharmaceuticals Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Nanopharmaceuticals Production Mode & Process

12.4 Nanopharmaceuticals Sales and Marketing

12.4.1 Nanopharmaceuticals Sales Channels

12.4.2 Nanopharmaceuticals Distributors

12.5 Nanopharmaceuticals Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Nanopharmaceuticals Industry Trends

13.2 Nanopharmaceuticals Market Drivers

13.3 Nanopharmaceuticals Market Challenges

13.4 Nanopharmaceuticals Market Restraints

14 Key Findings in The Global Nanopharmaceuticals Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample